EP1226271A2 - Dna sequencing method - Google Patents
Dna sequencing methodInfo
- Publication number
- EP1226271A2 EP1226271A2 EP00964544A EP00964544A EP1226271A2 EP 1226271 A2 EP1226271 A2 EP 1226271A2 EP 00964544 A EP00964544 A EP 00964544A EP 00964544 A EP00964544 A EP 00964544A EP 1226271 A2 EP1226271 A2 EP 1226271A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- enzyme
- polynucleotide
- label
- solid support
- polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Definitions
- This invention relates to polynucleotide sequence determinations . Background of the invention
- the ability to determine the sequence of a polynucleotide is of great scientific importance.
- the Human Genome Project is an ambitious international effort to map and sequence the three billion bases of DNA encoded in the human genome.
- the resulting sequence database will be a tool of unparalleled power for biomedical research.
- the major obstacle to the successful completion of this project concerns the technology used in the sequencing process.
- the principle method in general use for large-scale DNA sequencing is the chain termination method. This method was first developed by Sanger and Coulson (Sanger et al . , Proc. Natl. Acad. Sci .
- dideoxy derivatives of the four nucleoside triphosphates which are incorporated into a nascent polynucleotide chain in a polymerase reaction.
- the dideoxy derivatives terminate the polymerase reaction and the products are then separated by gel electrophoresis and analysed to reveal the position at which the particular dideoxy derivative was incorporated into the chain.
- the spectroscopic techniques described are surface plasmon resonance (SPR) spectroscopy, which measures changes in an analyte within an evanescent wave field, and fluorescence measuring techniques.
- SPR surface plasmon resonance
- fluorescence measuring techniques have the disadvantage of increasing background interference from the fluorophores incorporated on the growing nascent polynucleotide chain. As the chain grows, the background "noise" increases and the time required to detect each nucleotide incorporation needs to be increased. This severely restricts the use of the method for sequencing large polynucleotides .
- Single fragment polynucleotide sequencing approaches are outlined in WO-A-9924797 and WO-A-9833939 , both of which employ fluorescent detection of single labelled nucleotide molecules.
- These single nucleotides are cleaved from the template polynucleotide, held in a flow by an optical trap (Jett, et al . , J. Biomol . Struc . Dyn, 1989; 7:301-309), by the action of an exonuclease molecule. These cleaved nucleotides then flow downstream within a quartz flow cell, are subjected to laser excitation and then detected by a sensitive detection system.
- the present invention is based on the realisation that the sequence of a target polynucleotide can be determined by measuring conformational changes in an enzyme that binds to and processes along the target polynucleotide. The extent of the conformational change that takes place is different depending on which individual nucleotide on the target is in contact with the enzyme.
- a method for determining the sequence of a polynucleotide comprises the steps of:
- the enzyme is a polymerase enzyme which interacts with the target in the process of extending a complementary strand.
- the enzyme is typically immobilised on a solid support to localise the reaction within a defined area.
- the enzyme comprises a first bound detectable label, the characteristics of which alter as the enzyme undergoes a conformational change.
- the enzyme may also comprise a second bound detectable label capable of interacting with the first label, wherein the degree of interaction is dependent on a conformational change in the enzyme.
- the first label is an energy acceptor and the second label is an energy donor, and detecting the conformational change is carried out by measuring energy transfer between the two labels.
- fluorescence resonance energy transfer is used to detect a conformational change in an enzyme that interacts with and processes along a target polymerase, thereby determining the sequence of the polynucleotide.
- Fluorescence resonance energy transfer may be carried out between FRET donor and acceptor labels, each bound to the enzyme.
- one of the labels may be bound to the enzyme and the other label bound to the polynucleotide.
- a detectably-labelled enzyme capable of interacting with and precessing along a target polynucleotide, to determine the sequence of the polynucleotide, wherein the label alters its detectable characteristics as the enzyme processes along the polynucleotide.
- a solid support comprises at least one immobilised enzyme capable of interacting with and precessing along a target polynucleotide, the enzyme being labelled with one or more detectable labels.
- a system for determining the sequence of a polynucleotide comprises a solid support as defined above, and an apparatus for detecting the label.
- the present invention offers several advantages over conventional sequencing technology. Once a polymerase enzyme begins its round of polynucleotide elongation, it tends to polymerase several thousand nucleotides before falling off from the strand. Additionally, certain specific polymerase systems are able to anchor or tether themselves to the template polynucleotide via a 'sliding clamp 1 (e.g. Polymerase III) which encircles the template molecule or via a molecular hook (e.g. T7 : thireodoxin complex) which partially encircles the template.
- a 'sliding clamp 1 e.g. Polymerase III
- a molecular hook e.g. T7 : thireodoxin complex
- the invention may also enable tens of kilobases (kb) or more to be sequenced in one go, at a rate of hundreds of base pairs per second. This is a result of sequencing on a single fragment of DNA.
- An advantage of sequencing a single fragment of DNA is that sequencing rates are determined by the enzyme system utilised and not upon indirect, summated reactions, and are therefore correspondingly higher. Just as important as the high rate is the ability to sequence large fragments of DNA. This will significantly reduce the amount of subcloning and the number of overlapping sequences required to assemble megabase segments of sequencing information.
- Figure 2 illustrates a trace taken after fluorescence resonance energy transfer, with each of the peaks representing the detection of a specific nucleotide.
- the present method for sequencing a polynucleotide involves the analysis of conformational changes between an enzyme and a target polynucleotide.
- polynucleotide as used herein is to be interpreted broadly, and includes DNA and RNA, including modified DNA and RNA, as well as other hybridising nucleic acid-like molecules, e.g. peptide nucleic acid (PNA) .
- PNA peptide nucleic acid
- the enzyme may be a polymerase enzyme, and a conformational change is brought about when the polymerase incorporates a nucleotide into a nascent strand complementary to the target polynucleotide. It has been found that the conformational change will be different for each of the different nucleotides, A, T, G or C and therefore measuring the change will identify which nucleotide is incorporated.
- the enzyme may be any that is involved in an interaction with a polynucleotide, e.g. a helicase enzyme , primase and holoenzyme .
- a polynucleotide e.g. a helicase enzyme , primase and holoenzyme .
- the enzyme processes along the polynucleotide, its conformation will change depending on which nucleotide on the target it is brought into contact with.
- One way of detecting a conformational change in the enzyme is to measure resonance energy transfer between a suitable energy donor label and a suitable energy acceptor label .
- the donor and acceptor are each bound to the enzyme and the conformational change in the enzyme brought about by its interaction with the target polynucleotide alters the relative positioning of the labels.
- one label may be positioned on the enzyme and the other on a nucleotide of the target or on a nucleotide incorporated onto a strand complementary to the target .
- FRET fluorescence resonance energy transfer
- the present invention may also be carried out using measurement techniques that require only a single label. Any system that is capable of measuring changes in the local environment of the enzyme at the single molecule level, is an accepted embodiment of the invention.
- Various properties of single fluorescent probes attached to a polynucleotide processive enzyme and/or its substrate (s) can be exploited in the context of the invention to provide data on variables within or in close proximity to the enzyme system/molecular environment that are specific to a nucleotide incorporation event.
- Such variables include, but are not limited to, molecular interactions, enzymatic activity, reaction kinetics, conformational dynamics, molecular freedom of motion, and alterations in activity and in chemical and electrostatic environment .
- the absorption and emission transition dipoles of single fluorophores can be determined by using polarized excitation light or by analysing the emission polarisation, or both.
- the temporal variation in dipole orientation of a rigidly attached or rotationally diffusing tethered label can report on the angular motion of a macromolecule system or one of its subunits (Warshaw, et al . , Proc. Natl . Acad. Sci . USA, 1998; 95:8034) and therefore may be applied in the present invention.
- the label is a fluorescence label, such as those disclosed in Xue, et al . , Nature, 1995; 373:681.
- fluorescing enzymes such as green fluorescent protein (Lu, et al . , Science, 1998; 282:1877) can be employed.
- the preferred embodiment of the invention involves the use of small fluorescence molecules that are covalently and site-specifically attached to the polynucleotide processive enzyme, e.g. tetramethylrhodamine (TMR) .
- TMR tetramethylrhodamine
- fluorescent labels are used in the invention, their detection may be affected by photobleaching caused by repeated exposure to excitation wavelengths.
- One possible way to avoid this problem is to carry out many sequential reactions, but detecting fluorescence signals on only a few at a time. Using this iterative process, the correct sequence of signals can be determined and the polynucleotide sequence determined. For example, by immobilising a plurality of enzymes on a solid support and contacting them with the target polynucleotide, the sequencing reactions should start at approximately the same time. Excitation and detection of fluorescence can be localised to a proportion of the total reactions, for a time until photobleaching becomes evident. At this time, excitation and detection can be transferred to a different proportion of the reactions to continue the sequencing.
- the labels may be attached to the enzymes by covalent or other linkages.
- a number of strategies may be used to attach the labels to the enzyme. Strategies include the use of site-directed mutagenesis and unnatural amino acid mutagenesis (Anthony-Cahi1 , et al . , Trends Biochem. Sci., 1989; 14:400) to introduce cysteine and ketone handles for specific and orthogonal dye labelling proteins (Cornish, et al . , Proc. Natl. Acad. Sci. USA, 1994; 91:2910).
- GFP green fluorescent protein
- polymerase e.g. polymerase
- GFP green fluorescent protein
- This technique has been demonstrated to be applicable to the measurement of conformational changes (Miyawaki, et al . , Nature, 1997; 388:882) and local pH changes (Llopis, et al . , Proc. Natl. Acad. Sci. USA, 1998; 95:6803). Supports suitable for use in immobilising the enzymes, will be apparent to the skilled person.
- Enzyme immobilisation may be carried out by covalent or other means.
- covalent linker molecules may be used to attach to a suitably prepared enzyme . Attachment methods are known to the skilled person.
- Resonance energy transfer may be measured by the techniques of surface plasmon resonance (SPR) or fluorescent surface plasmon resonance .
- spectroscopy by total internal reflectance fluorescence (TIRF) , attenuated total reflection (ATR) , frustrated total reflection (FTR) , Brewster angle reflectometry, scattered total internal reflection (STIR) , fluorescence lifetime imaging microscopy and spectroscopy (FLIMS) , fluorescence polarisation anisotrophy (FPA) , fluorescence spectroscopy, or evanescent wave ellipsometry.
- TIRF total internal reflectance fluorescence
- ATR attenuated total reflection
- FTR frustrated total reflection
- TSR frustrated total reflection
- HTR scattered total internal reflection
- FLIMS fluorescence lifetime imaging microscopy and spectroscopy
- FPA fluorescence polarisation anisotrophy
- fluorescence spectroscopy or evanescent wave ellipsometry.
- This Example used a confocal fluorescence setup, as shown in Fig. 1.
- the setup consists of a scan table (1) able to scan at high resolution in X, Y and Z dimensions, a class coverslip (2) which is part of a microfluidic flow cell system with an inlet (8) for introducing the primer-template polynucleotide complex (4) and nucleotides over the immobilised (9) polymerase molecule (3) within a buffer, and an outlet (7) for waste.
- Incident light from a laser light source (6) for donor excitation is delivered via an oil-immersion objective (5) .
- TMR Tetramethylrhodamine
- Cy5 acceptor
- T7 DNA Polymerase from New England Biolabs (supplied at 10 000 U/ml) was used. 50 ⁇ l of T7 was bu fer-exchanged in a Vivaspin 500 (Vivaspin) against 4 x 500 ⁇ l of 200mM Sodium Acetate buffer at pH 4 in order to remove the DTT from the storage buffer that the T7 DNA Polymerase is supplied in. Then, 50 ⁇ l of the buffer-exchanged T7 DNA polymerase was added to lOO ⁇ l of Sodium Acetate buffer at pH 4 and 50 ⁇ l saturated 2-2-DiPyridyl-DiSulphide in aqueous solution. This reaction was then left for 110 minutes and the absorption at 343nm noted. Finally, the sample was then buffer-exchanged into 200mM Tris at pH 8 as before (4 times 500 ⁇ l) . Dye attachment was verified by denaturing polyacrylamide gel electrophoresis. Cy5 succinimidyl ester
- Glass coverslips were derivatized with N-[(3- trimethoxysilyDpropyl] ethylenediamine triacetic acid. The coverslip was then glued into a flow-cell arrangement that allowed buffer to be flowed continuously over the derivatized glass surface. The labelled polymerase was then added to the buffer and allowed to flow over the coverslip so that protein was immobilised on the glass surface .
- Proteins were then immobilised on the glass-water interface with low density so that only one molecule was under the laser excitation volume at any one time.
- Laser light (514 nm Ar ion laser, 15 ⁇ W, circularly polarized) was focused onto a 0.4 ⁇ m spot using an oil immersion objective in an epi- illumination setup of a scanning-stage confocal microscope.
- the fluorescence emission was collected by the same objective and divided into two by a dichroic beam splitter (long pass at 630 nm) and detected by two Avalanche Photo Diode (APD) counting units, simultaneously.
- APD Avalanche Photo Diode
- a 585 nm band pass filter was placed in front of the donor detector; a 650 nm long pass filter was placed in front of the acceptor detector. Since the spectral ranges during fluorescence detection are sufficiently removed from the cutoff wavelength of the dichroic beam splitter, the polarization dependence of the detection efficiency of both donor and acceptor signal is negligible. It has been shown that the polarization mixing due to the high near field aperture (NA) objective can be overlooked (Ha et al , Supra) .
- NA near field aperture
- oligonucleotides Two oligonucleotides were synthesised using standard phosphoramidite chemistry.
- the oligonucleotide defined as SEQ ID NO.l was used as the target polynucleotide, and the oligonucleotide defined as SEQ ID No.2 was used as the primer.
- the two oligonucleotides were reacted under hybridizing conditions to form the target-primer complex.
- the reaction was then initiated by injecting the primed DNA into the flow cell with all four nucleotides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9923644.0A GB9923644D0 (en) | 1999-10-06 | 1999-10-06 | DNA sequencing |
GB9923644 | 1999-10-06 | ||
PCT/GB2000/003860 WO2001025480A2 (en) | 1999-10-06 | 2000-10-06 | Dna sequencing method |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1226271A2 true EP1226271A2 (en) | 2002-07-31 |
EP1226271B1 EP1226271B1 (en) | 2008-03-05 |
Family
ID=10862234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00964544A Expired - Lifetime EP1226271B1 (en) | 1999-10-06 | 2000-10-06 | Dna sequencing method |
Country Status (21)
Country | Link |
---|---|
US (4) | US20050214849A1 (en) |
EP (1) | EP1226271B1 (en) |
JP (2) | JP5030249B2 (en) |
KR (1) | KR100809171B1 (en) |
CN (1) | CN1159457C (en) |
AT (1) | ATE388242T1 (en) |
AU (1) | AU769102B2 (en) |
BR (1) | BR0014468A (en) |
CA (1) | CA2386115C (en) |
DE (1) | DE60038244T2 (en) |
DK (1) | DK1226271T3 (en) |
EA (1) | EA006702B1 (en) |
ES (1) | ES2302497T3 (en) |
GB (1) | GB9923644D0 (en) |
HK (1) | HK1045857A1 (en) |
IL (2) | IL148678A0 (en) |
IS (1) | IS6333A (en) |
MX (1) | MXPA02003534A (en) |
NZ (1) | NZ517775A (en) |
PT (1) | PT1226271E (en) |
WO (1) | WO2001025480A2 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE225858T1 (en) * | 1997-07-28 | 2002-10-15 | Medical Biosystems Ltd | SEQUENCE ANALYSIS OF NUCLEIC ACIDS |
US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US7875440B2 (en) | 1998-05-01 | 2011-01-25 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
GB9907812D0 (en) * | 1999-04-06 | 1999-06-02 | Medical Biosystems Ltd | Sequencing |
EP1681356B1 (en) | 1999-05-19 | 2011-10-19 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
GB9923644D0 (en) * | 1999-10-06 | 1999-12-08 | Medical Biosystems Ltd | DNA sequencing |
EP1975251A3 (en) | 2000-07-07 | 2009-03-25 | Visigen Biotechnologies, Inc. | Real-time sequence determination |
EP1354064A2 (en) | 2000-12-01 | 2003-10-22 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
GB0112238D0 (en) * | 2001-05-18 | 2001-07-11 | Medical Biosystems Ltd | Sequencing method |
US6956114B2 (en) | 2001-10-30 | 2005-10-18 | '454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6902921B2 (en) | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
SE0201655D0 (en) * | 2002-05-31 | 2002-05-31 | Amersham Biosciences Ab | A method of electrophoresis |
JP2007529999A (en) * | 2003-07-15 | 2007-11-01 | デンシャム,ダニエル,ヘンリー | Measurement of polynucleotide amplification reaction |
GB0317343D0 (en) * | 2003-07-24 | 2003-08-27 | Medical Biosystems Ltd | Polynucleotide sequencing |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
EP3373174A1 (en) * | 2006-03-31 | 2018-09-12 | Illumina, Inc. | Systems and devices for sequence by synthesis analysis |
GB0721340D0 (en) * | 2007-10-30 | 2007-12-12 | Isis Innovation | Polymerase-based single-molecule DNA sequencing |
CA2991818C (en) | 2008-03-28 | 2022-10-11 | Pacific Biosciences Of California, Inc. | Compositions and methods for nucleic acid sequencing |
US9182406B2 (en) * | 2008-08-04 | 2015-11-10 | Biodesy, Inc. | Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability |
WO2010068884A2 (en) * | 2008-12-11 | 2010-06-17 | The Regents Of The University Of California | Methods and systems for direct sequencing of single dna molecules |
US8911972B2 (en) | 2009-12-16 | 2014-12-16 | Pacific Biosciences Of California, Inc. | Sequencing methods using enzyme conformation |
WO2011159942A1 (en) | 2010-06-18 | 2011-12-22 | Illumina, Inc. | Conformational probes and methods for sequencing nucleic acids |
WO2012129347A1 (en) | 2011-03-21 | 2012-09-27 | Biodesy, Llc | Classification of kinase inhibitors using nonlinear optical techniques |
DE102013202721A1 (en) * | 2013-02-20 | 2014-08-21 | Siemens Aktiengesellschaft | A sequencing device for sequencing at least one nucleic acid single strand and methods for sequencing at least one nucleic acid single strand |
GB201306444D0 (en) * | 2013-04-09 | 2013-05-22 | Base4 Innovation Ltd | Single nucleotide detection method |
US10605766B2 (en) | 2014-07-15 | 2020-03-31 | Illumina, Inc. | Biochemically activated electronic device |
EP3237906B8 (en) | 2014-12-23 | 2020-10-28 | Bluelight Therapeutics, Inc. | Attachment of proteins to interfaces for use in nonlinear optical detection |
US10077470B2 (en) | 2015-07-21 | 2018-09-18 | Omniome, Inc. | Nucleic acid sequencing methods and systems |
AU2017258619B2 (en) | 2016-04-29 | 2020-05-14 | Pacific Biosciences Of California, Inc. | Sequencing method employing ternary complex destabilization to identify cognate nucleotides |
JP6828140B2 (en) | 2016-08-15 | 2021-02-10 | オムニオム インコーポレイテッドOmniome, Inc. | Methods and systems for sequencing nucleic acids |
WO2018034780A1 (en) | 2016-08-15 | 2018-02-22 | Omniome, Inc. | Sequencing method for rapid identification and processing of cognate nucleotide pairs |
WO2018125759A1 (en) | 2016-12-30 | 2018-07-05 | Omniome, Inc. | Method and system employing distinguishable polymerases for detecting ternary complexes and identifying cognate nucleotides |
CA3050695C (en) | 2017-01-20 | 2024-02-20 | Omniome, Inc. | Process for cognate nucleotide detection in a nucleic acid sequencing workflow |
US10161003B2 (en) | 2017-04-25 | 2018-12-25 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
US9951385B1 (en) | 2017-04-25 | 2018-04-24 | Omniome, Inc. | Methods and apparatus that increase sequencing-by-binding efficiency |
WO2019055867A1 (en) * | 2017-09-15 | 2019-03-21 | Illumina, Inc. | Sequence-detection system |
CA3079411C (en) | 2017-10-19 | 2023-12-05 | Omniome, Inc. | Simultaneous background reduction and complex stabilization in binding assay workflows |
US11499962B2 (en) | 2017-11-17 | 2022-11-15 | Ultima Genomics, Inc. | Methods and systems for analyte detection and analysis |
US10267790B1 (en) | 2017-11-17 | 2019-04-23 | Ultima Genomics, Inc. | Systems for biological sample processing and analysis |
US10512911B1 (en) * | 2018-12-07 | 2019-12-24 | Ultima Genomics, Inc. | Implementing barriers for controlled environments during sample processing and detection |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE462454B (en) | 1988-11-10 | 1990-06-25 | Pharmacia Ab | METHOD FOR USE IN BIOSENSORS |
GB8910880D0 (en) * | 1989-05-11 | 1989-06-28 | Amersham Int Plc | Sequencing method |
CA2044616A1 (en) | 1989-10-26 | 1991-04-27 | Roger Y. Tsien | Dna sequencing |
US5583026A (en) * | 1994-08-31 | 1996-12-10 | Cornell Research Foundation, Inc. | Process for reconstituting the polymerase III* and other subassemblies of E. coli DNA polymerase III holoenzyme from peptide subunits |
GB9208733D0 (en) | 1992-04-22 | 1992-06-10 | Medical Res Council | Dna sequencing method |
US5360714A (en) * | 1992-08-28 | 1994-11-01 | Fox Chase Cancer Center | Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof |
CA2158642A1 (en) | 1993-03-19 | 1994-09-29 | Hubert Koster | Dna sequencing by mass spectrometry via exonuclease degradation |
WO1995006138A1 (en) * | 1993-08-25 | 1995-03-02 | The Regents Of The University Of California | Microscopic method for detecting micromotions |
US5747247A (en) * | 1994-07-25 | 1998-05-05 | The Regents Of The University Of California | Spectroscopic helicase assay |
US5801042A (en) * | 1994-08-18 | 1998-09-01 | The Trustees Of Columbia University In The City Of New York | Unique associated Kaposi's sarcoma virus sequences and uses thereof |
US5753439A (en) * | 1995-05-19 | 1998-05-19 | Trustees Of Boston University | Nucleic acid detection methods |
DE69825601T2 (en) * | 1997-02-12 | 2005-04-28 | Chan, Eugene Y, Brookline | METHOD FOR THE ANALYSIS OF POLYMERS |
JP2001514511A (en) * | 1997-03-05 | 2001-09-11 | スクリプトゲン ファーマシューティカルズ インク | Screening using fluorescence anisotropy to identify compounds with affinity for nucleic acids |
US6159687A (en) * | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods for generating recombined polynucleotides |
ATE225858T1 (en) | 1997-07-28 | 2002-10-15 | Medical Biosystems Ltd | SEQUENCE ANALYSIS OF NUCLEIC ACIDS |
US7875440B2 (en) * | 1998-05-01 | 2011-01-25 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6210896B1 (en) * | 1998-08-13 | 2001-04-03 | Us Genomics | Molecular motors |
US6263286B1 (en) * | 1998-08-13 | 2001-07-17 | U.S. Genomics, Inc. | Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer |
AU5560699A (en) | 1998-08-13 | 2000-03-06 | U.S. Genomics, Inc. | Optically characterizing polymers |
ES2310514T3 (en) * | 1999-03-10 | 2009-01-16 | Asm Scientific, Inc. | A METHOD FOR DIRECT SEQUENCING OF NUCLEIC ACID. |
GB9907812D0 (en) * | 1999-04-06 | 1999-06-02 | Medical Biosystems Ltd | Sequencing |
US7056661B2 (en) * | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
US6335420B1 (en) | 1999-11-22 | 2002-01-01 | Ibc Advanced Technologies, Inc. | Polyamide ligand-containing polymeric resins and methods of using the same for removing, separating and/or concentrating desired metal ions from solutions |
US6908736B1 (en) * | 1999-10-06 | 2005-06-21 | Medical Biosystems, Ltd. | DNA sequencing method |
GB9923644D0 (en) | 1999-10-06 | 1999-12-08 | Medical Biosystems Ltd | DNA sequencing |
GB0112238D0 (en) | 2001-05-18 | 2001-07-11 | Medical Biosystems Ltd | Sequencing method |
GB0317343D0 (en) * | 2003-07-24 | 2003-08-27 | Medical Biosystems Ltd | Polynucleotide sequencing |
GB0413082D0 (en) | 2004-06-11 | 2004-07-14 | Medical Biosystems Ltd | Method |
US8262900B2 (en) * | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US20100301398A1 (en) * | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US20100137143A1 (en) * | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US8673627B2 (en) * | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
US8574835B2 (en) * | 2009-05-29 | 2013-11-05 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
-
1999
- 1999-10-06 GB GBGB9923644.0A patent/GB9923644D0/en not_active Ceased
-
2000
- 2000-10-06 MX MXPA02003534A patent/MXPA02003534A/en unknown
- 2000-10-06 NZ NZ517775A patent/NZ517775A/en unknown
- 2000-10-06 AT AT00964544T patent/ATE388242T1/en not_active IP Right Cessation
- 2000-10-06 CA CA2386115A patent/CA2386115C/en not_active Expired - Lifetime
- 2000-10-06 DE DE60038244T patent/DE60038244T2/en not_active Expired - Lifetime
- 2000-10-06 PT PT00964544T patent/PT1226271E/en unknown
- 2000-10-06 DK DK00964544T patent/DK1226271T3/en active
- 2000-10-06 EP EP00964544A patent/EP1226271B1/en not_active Expired - Lifetime
- 2000-10-06 AU AU75467/00A patent/AU769102B2/en not_active Expired
- 2000-10-06 JP JP2001528630A patent/JP5030249B2/en not_active Expired - Fee Related
- 2000-10-06 IL IL14867800A patent/IL148678A0/en unknown
- 2000-10-06 ES ES00964544T patent/ES2302497T3/en not_active Expired - Lifetime
- 2000-10-06 BR BR0014468-1A patent/BR0014468A/en not_active Application Discontinuation
- 2000-10-06 EA EA200200428A patent/EA006702B1/en not_active IP Right Cessation
- 2000-10-06 CN CNB008137854A patent/CN1159457C/en not_active Expired - Lifetime
- 2000-10-06 WO PCT/GB2000/003860 patent/WO2001025480A2/en active IP Right Grant
- 2000-10-06 KR KR1020027004272A patent/KR100809171B1/en not_active IP Right Cessation
-
2002
- 2002-03-13 IL IL148678A patent/IL148678A/en not_active IP Right Cessation
- 2002-04-05 IS IS6333A patent/IS6333A/en unknown
- 2002-08-23 HK HK02106240A patent/HK1045857A1/en not_active IP Right Cessation
-
2005
- 2005-05-11 US US11/126,481 patent/US20050214849A1/en not_active Abandoned
-
2010
- 2010-02-22 US US12/710,059 patent/US7939264B1/en not_active Expired - Fee Related
-
2011
- 2011-03-29 US US13/074,949 patent/US20110177520A1/en not_active Abandoned
- 2011-12-01 JP JP2011264043A patent/JP2012196201A/en active Pending
-
2012
- 2012-05-04 US US13/464,285 patent/US20120214164A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO0125480A2 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7939264B1 (en) | DNA sequencing method | |
US6908736B1 (en) | DNA sequencing method | |
EP2267164B1 (en) | Nucleic acid sequence analysis | |
US9382584B2 (en) | Methods and systems for direct sequencing of single DNA molecules | |
US6524829B1 (en) | Method for DNA- or RNA-sequencing | |
US20090011514A1 (en) | Dna Crosslinking for Primer Extension Assays | |
MXPA00000715A (en) | Nucleic acid sequence analysis | |
AU4382801A (en) | Nucleic acid sequence analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020417 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20030923 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60038244 Country of ref document: DE Date of ref document: 20080417 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20080512 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. AG PATENT- UND MARKENANWAELTE VSP |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20080401309 Country of ref document: GR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2302497 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1045857 Country of ref document: HK |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20081217 Year of fee payment: 9 Ref country code: MC Payment date: 20081211 Year of fee payment: 9 |
|
26N | No opposition filed |
Effective date: 20081208 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20081205 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20081215 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081006 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20100406 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20100226 Year of fee payment: 10 Ref country code: DK Payment date: 20100301 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20100301 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20100301 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100406 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20100916 AND 20100922 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100504 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20100303 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP Ref country code: FR Ref legal event code: CA Ref country code: FR Ref legal event code: CD |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A Owner name: GEN-PROBE INCORPORATED Effective date: 20110412 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091006 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101006 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101006 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20121008 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20131025 Year of fee payment: 14 Ref country code: BE Payment date: 20131028 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20140501 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140501 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141031 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141006 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20191029 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20191023 Year of fee payment: 20 Ref country code: FR Payment date: 20191025 Year of fee payment: 20 Ref country code: ES Payment date: 20191104 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20191028 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 60038244 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20201005 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20210126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20201005 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20201007 |